Literature DB >> 19962283

Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of India.

Thulasi G Pillai1, Mathew John, Gifty Sara Thomas.   

Abstract

Investigations were carried out to determine the protective effect of terpenes isolated from the fruiting bodies of Ganoderma lucidum (Fr) P.Karst against nephrotoxicity caused by the cisplatin, in mice. Intraperitoneal administration of cisplatin (16 mg/kg body wt) resulted in significant nephrotoxicity in mice. Serum urea, creatinine and ALP levels were drastically elevated indicating severe nephrotoxicity . The renal antioxidant defense system such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and concentration of reduced glutathione (GSH) were depleted by cisplatin injection. The oral administration of terpenes at a dose of 100mg/kg body weight prevented increase in urea, creatinine levels and ALP activity and also maintained the renal antioxidant defense. The Ganoderma terpenes also imparted protection against cisplatin induced renal tissue lipid peroxidation. The results indicated that the total terpenes isolated from G. lucidum possessed significant in vivo antioxidant activity and rendered protection against cisplatin induced nephrotoxicity. The results suggest the potential therapeutic use of Ganoderma terpenes to prevent nephrotoxicity caused during chemotherapy using cisplatin.
Copyright © 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962283     DOI: 10.1016/j.etp.2009.11.003

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  8 in total

1.  Antioxidant and Nephroprotective Activities of the Extract and Fractions of Homonoia riparia Lour.

Authors:  Seena Kanniparambil Xavier; Shoja Muhammed Haneefa; Devkar Raviraj Anand; Picheswara Rao Polo; Rajalekshmi Maheshwari; Chandrashekara Shastry Shreedhara; Manganahalli Manjunath Setty
Journal:  Pharmacogn Mag       Date:  2017 Jan-Mar       Impact factor: 1.085

2.  Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.

Authors:  Ivette J Suárez-Arroyo; Yaliz Loperena-Alvarez; Raysa Rosario-Acevedo; Michelle M Martínez-Montemayor
Journal:  Medicines (Basel)       Date:  2017-03-15

Review 3.  Herb-drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review.

Authors:  Chun Sing Lam; Lok Pui Cheng; Li Min Zhou; Yin Ting Cheung; Zhong Zuo
Journal:  Chin Med       Date:  2020-07-25       Impact factor: 5.455

4.  Biotoxicological Analyses of Trimeroside from Baccharis trimera Using a Battery of In Vitro Test Systems.

Authors:  Marcela Silva Dos Santos; Juliana da Silva; Ana Paula Simões Menezes; Francisco Maikon Corrêa de Barros; Maria Luisa Brodt Lemes; Raíssa R Rossatto; Cleverson Feistel; Indara Dedigo de Almeida; Ivana Grivicich; Lismare Prado; Jaqueline Nascimento Picada; Alexandre de Barros Falcão Ferraz
Journal:  Oxid Med Cell Longev       Date:  2018-08-19       Impact factor: 6.543

5.  Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways.

Authors:  Xiao-Qiang Geng; Ang Ma; Jin-Zhao He; Liang Wang; Ying-Li Jia; Guang-Ying Shao; Min Li; Hong Zhou; Shu-Qian Lin; Jian-Hua Ran; Bao-Xue Yang
Journal:  Acta Pharmacol Sin       Date:  2019-12-05       Impact factor: 6.150

6.  Protective role of Emblica officinalis hydro-ethanolic leaf extract in cisplatin induced nephrotoxicity in Rats.

Authors:  Rupal Purena; Rohit Seth; Renu Bhatt
Journal:  Toxicol Rep       Date:  2018-02-03

7.  Ganoderma lucidum Prevents Cisplatin-Induced Nephrotoxicity through Inhibition of Epidermal Growth Factor Receptor Signaling and Autophagy-Mediated Apoptosis.

Authors:  Yasmen F Mahran; Hanan M Hassan
Journal:  Oxid Med Cell Longev       Date:  2020-07-06       Impact factor: 6.543

8.  Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial.

Authors:  Jie Liu; Jun J Mao; Susan Qing Li; Hongsheng Lin
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.